Cholesterol Lowering Drugs Stall Disease Progression In People With Below-Average Blood Cholesterol Level

ing, by whatever means, would have a beneficial effect on the atherosclerosis. But the specific results that we have are for cholesterol lowering with pravastatin. I think it would probably be unwise to generalize much further beyond that," MacMahon says.

Pravastatin is one of a group of cholesterol-lowering drugs known as HMG-CoA reductase inhibitors. They work by interfering with the body's natural ability to make cholesterol.

The new findings have implications for treating patients with average or low cholesterol but who have an elevated risk of heart attack, the nation's leading cause of death, and stroke, the third leading cause of death and the leading cause of serious, long-term disability, he says.

The study was carried out in Auckland, using 522 participants from a larger study of New Zealand and Australian coronary heart disease patients called LIPID (Long-term Intervention with Pravastatin in Ischemic Disease). LIPID ended last summer after six years, a year earlier than planned, when it was found pravastatin lowered the risk of death without causing harm to patients.

MacMahon and his colleagues undertook the smaller study, known as the LIPID Atherosclerosis Substudy, to determine if reducing blood cholesterol in people with low or average levels would reduce the development of atherosclerosis. "At the time we started the study, there was great uncertainty about whether it would be beneficial to lower cholesterol in people who have average cholesterol," MacMahon says. "There really was very little evidence, and of course, most patients with coronary heart disease have cholesterol levels that are fairly average."

Co-authors of the paper are Norman Sharpe, M.D.; Greg Gamble, M.Sc.; Hamish Hart, M.B.; John Scott, M.D.; John Simes, M.D.; and Harvey White, D.Sc.


Contact: Carole Bullock
American Heart Association

Page: 1 2 3

Related biology news :

1. Cholesterol lowering drug effective in treating most common form of multiple sclerosis
2. Cholesterol-independent benefits of statins in cardiac hypertrophy
3. Cholesterol levels not necessarily indicative of cardiac health
4. Women With Low Cholesterol May Be At Risk For Depression And Anxiety
5. Structure Of HDL Cholesterol Determined
6. Discovery Of A Molecule That Controls Bile Acids May Lead To New Cholesterol Drugs
7. Researchers Learn How Nature Produces Cholesterol-Lowering Lovastatin
8. New Insights About Good Cholesterol
9. New Gene May Play Important Role In Regulating HDL, The Good Cholesterol
10. Chinese Condiment Cuts Blood Cholesterol
11. Blue-Green Algae Has Dual Cholesterol Lowering Abilities

Post Your Comments:

(Date:8/1/2019)... ... July 31, 2019 , ... Molecular Devices, LLC, a leader ... generation of its FLIPR® Penta High-Throughput Cellular Screening System. , The new FLIPR ... of G-protein-coupled receptors (GPCRs) and ion channels, offering a new high-speed camera option ...
(Date:7/26/2019)... ... July 25, 2019 , ... Lemnis Technologies, the technology ... to include a new generation eye tracker with hassle-free calibration. The headsets will ... (July 30 - August 1). SIGGRAPH attendees will be able to try Verifocal™ ...
(Date:7/23/2019)... (PRWEB) , ... July 23, 2019 , ... ... of NanoSTRIP, a 100% bioactive glass synthetic biologic strip indicated for spine and ... (HA) similar to human bone. Bioactive glass has been clinically-proven in orthopedics for ...
Breaking Biology News(10 mins):
(Date:6/18/2019)... (PRWEB) , ... June 18, 2019 , ... Personalized ... Investigational New Drug (IND) application to the FDA for use of a person’s own ... as a treatment of osteoarthritis in the knee. This IND is the first ...
(Date:6/11/2019)... ... June 10, 2019 , ... Advancements with Ted ... episode, scheduled to broadcast 4Q/2019. Check your local listings for more information. , ... about how its technology facilitates laboratories to improve efficiency and quality of research ...
(Date:6/11/2019)... ... 11, 2019 , ... Veterinary Regenerative Medicine company, VetStem ... announced that their GMP facility for cell production is now approved by the ... is an important milestone for VetStem as it expands into contract cell manufacturing ...
(Date:5/31/2019)... ... 2019 , ... For many years, the primary forms of cancer treatment have ... Advances in immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR ... receptors known as “CARs”. The CAR enables the final product to produce chemicals in ...
Breaking Biology Technology:
Cached News: